Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study

Bulevirtide effectively reduces HDV RNA levels and improves liver function with a favorable safety profile, offering a promising therapeutic option for chronic hepatitis D. Further large-scale studies are needed to confirm these findings and explore long-term outcomes.

Authors

Institutions

Publication Details

Journal
Viruses
Published
2025-02-12
DOI
https://doi.org/10.3390/v17020251
Citations
5
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
6.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study

Rosa Cotugno, Paolo Gallo, Luca Rinaldi, Elisabetta Falbo et al.
5 citations
Viruses
Hepatitis C virus research
6.61
article

Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study

Rosa Cotugno, Paolo Gallo, Luca Rinaldi, Elisabetta Falbo, Nicolina Capoluongo, F. Benanti, Francesca Terracciani, Mauro Viganò, Alessandro Loglio, Vincenzo Messina, Umberto Vespasiani‐Gentilucci, Rodolfo Sacco, Alessandro Perrella, Letizia Marinaro, Maurizio Russello, Alfredo Caturano, Valerio Rosato, Andrea Mormone, Ferdinando Carlo Sasso, Alessia Ciancio, Carlo Acierno, Emanuela Ciracì, Marco Distefano, Carlo Cosentino, Grazia Anna Niro, Giovanni Villone, Aldo Marrone, Ernesto Claar, Giulio Petronio Petronio, Antonio Izzi, M.R. Cannavò, Valeria Pace Palitti, Giuseppe Cariti, Chiara Petrucciello
article en
5 citations

Abstract

Bulevirtide effectively reduces HDV RNA levels and improves liver function with a favorable safety profile, offering a promising therapeutic option for chronic hepatitis D. Further large-scale studies are needed to confirm these findings and explore long-term outcomes.

VirusesVol. 17(2)
University of Foggia (IT), University of Molise (IT), University of Campania "Luigi Vanvitelli" (IT), Casa Sollievo della Sofferenza (IT), University of Catania (IT), Ospedale San Carlo (IT), Ospedale Garibaldi (IT), Ospedale Papa Giovanni XXIII (IT), Villa Pineta Hospital (IT), Campus Bio Medico University Hospital (IT), Azienda USL di Pescara (IT), Ospedale Sant'Anna (IT), Ospedale D. Cotugno (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), BioAge (Italy) (IT), University of Turin (IT)
Good health and well-being
Openalex Percentile: Top 3%
Hepatitis C virus research
6.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.